MCID: CHL067
MIFTS: 57

Cholecystitis malady

Categories: Rare diseases, Gastrointestinal diseases

Aliases & Classifications for Cholecystitis

Aliases & Descriptions for Cholecystitis:

Name: Cholecystitis 12 50 29 52 42 14 69
Acute Cholecystitis 12 52 14 69
Chronic Cholecystitis 12 52 69
Acute and Chronic Cholecystitis 12 69
Acalculous Cholecystitis 50 69
Calculus of Gallbladder with Cholecystitis 69
Acute Cholecystitis Unspecified 12
Acute on Chronic Cholecystitis 12
Acute Cholecystitis Nos 12
Gallstone Cholecystitis 50

Classifications:



External Ids:

Disease Ontology 12 DOID:1949
ICD9CM 35 575.10
MeSH 42 D002764
NCIt 47 C34465
SNOMED-CT 64 197414008 76581006
UMLS 69 C0008325

Summaries for Cholecystitis

Disease Ontology : 12 A cholangitis that is characterized_by an inflammation that is located in the gallbladder.

MalaCards based summary : Cholecystitis, also known as acute cholecystitis, is related to hemolytic-uremic syndrome and acalculous cholecystitis. An important gene associated with Cholecystitis is CCK (Cholecystokinin), and among its related pathways/superpathways are Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS) and Bladder cancer. The drugs Lidocaine and Ursodeoxycholic acid have been mentioned in the context of this disorder. Affiliated tissues include liver, b cells and testes, and related phenotypes are cellular and digestive/alimentary

Wikipedia : 71 Cholecystitis is inflammation of the gallbladder. Symptoms include right upper abdominal pain, nausea,... more...

Related Diseases for Cholecystitis

Diseases related to Cholecystitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 325)
id Related Disease Score Top Affiliating Genes
1 hemolytic-uremic syndrome 29.6 ALB F2 GPT
2 acalculous cholecystitis 12.3
3 emphysematous cholecystitis 12.2
4 xanthogranulomatous cholecystitis 12.1
5 gallbladder disease 1 11.5
6 mirizzi syndrome 11.1
7 dicrocoeliasis 10.8
8 opisthorchiasis 10.8
9 erythrocytosis due to bisphosphoglycerate mutase deficiency 10.8
10 linitis plastica 10.3 CDH1 TP53
11 nondystrophic myotonia 10.3 ALB F2
12 bronchitis 10.3 CDH1 TP53
13 familial progressive hyperpigmentation 10.3 F2 GPT
14 clear cell adenofibroma 10.2 CDKN2A TP53
15 lacrimal gland adenoid cystic carcinoma 10.2 CDKN2A TP53
16 polycythemia due to hypoxia 10.2 CCK GUSB
17 freiberg's disease 10.2 ALB F2
18 pericardium leiomyoma 10.2 CDKN2A TP53
19 atrophic vulva 10.2 ALB CCK F2
20 female infertility of uterine origin 10.2 ALB F2 GPT
21 bile duct cystadenocarcinoma 10.2 ALB F2 GPT
22 retinal arterial macroaneurysm with supravalvular pulmonic stenosis 10.2 ALB F2 GPT
23 acute monocytic leukemia 10.2 ALB F2 GPT
24 hereditary alpha tryptasemia syndrome 10.2 ALB F2 GPT
25 benign deep fibrous histiocytoma 10.2 ALB F2 GPT
26 spondylarthropathy 10.2 CDKN2A TP53
27 heart aneurysm 10.2 ALB CCK F2
28 postpoliomyelitis syndrome 10.2 CCK CDKN2A TP53
29 cholelithiasis 10.2
30 paranasal sinus sarcoma 10.2 ALB F2 GPT
31 congenital hypoplastic anemia 10.2 ALB F2 GPT
32 amelogenesis imperfecta 10.2 ALB F2 GPT
33 fiedler's myocarditis 10.2 ALB F2 GPT
34 ovarian squamous cell carcinoma 10.2 CDH1 MUC6
35 maternally-inherited cardiomyopathy and hearing loss 10.2 ALB MUC2
36 estrogen-receptor positive breast cancer 10.2 CDH1 CDKN2A TP53
37 bacterial meningitis 10.2 ALB F2 GPT
38 nodular cutaneous amyloidosis 10.2 CDH1 CDKN2A TP53
39 pyomyositis 10.2 CDH1 CDKN2A TP53
40 maxillary sinus cholesteatoma 10.2 CDH1 CDKN2A TP53
41 connective tissue benign neoplasm 10.2 CDH1 CDKN2A TP53
42 hepatitis 10.1
43 spastic ataxia 5 10.1 CDKN2A MUC6 TP53
44 borderline leprosy 10.1 ALB CCK GPT GUSB
45 traumatic brain injury 10.1 CDH1 CDKN2A TP53
46 gastrointestinal adenoma 10.1 ALB CCK F2 GPT
47 pancreatitis 10.1
48 ornithinemia 10.1 CDH1 CDKN2A TP53
49 dental caries 10.1 CDH1 MUC1 TP53
50 nasal cavity disease 10.1 CDH1 MUC1 TP53

Comorbidity relations with Cholecystitis via Phenotypic Disease Network (PDN): (show all 13)


Acute Cystitis Acute Pancreatitis
Cholangitis Cholestasis
Chronic Myocardial Ischemia Deficiency Anemia
Esophagitis Familial Atrial Fibrillation
Heart Disease Hypertension, Essential
Ischemic Heart Disease Paralytic Ileus
Protein-Energy Malnutrition

Graphical network of the top 20 diseases related to Cholecystitis:



Diseases related to Cholecystitis

Symptoms & Phenotypes for Cholecystitis

MGI Mouse Phenotypes related to Cholecystitis:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 9.97 ALB CDH1 CDKN2A DAPK1 GUSB HP
2 digestive/alimentary MP:0005381 9.8 ALB CDH1 CDKN2A F2 MUC2 RUNX3
3 endocrine/exocrine gland MP:0005379 9.76 ALB CCK CDH1 CDKN2A GUSB MUC2
4 homeostasis/metabolism MP:0005376 9.7 CDKN2A DAPK1 F2 GUSB HP MUC2
5 neoplasm MP:0002006 9.1 TP53 ALB CDH1 CDKN2A HP MUC2

Drugs & Therapeutics for Cholecystitis

Drugs for Cholecystitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 148)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
2
Ursodeoxycholic acid Approved, Investigational Phase 4 128-13-2 31401
3
Ceftriaxone Approved Phase 4,Phase 2 73384-59-5 5479530 5361919
4
Dexmedetomidine Approved, Vet_approved Phase 4 76631-46-4, 113775-47-6 68602 5311068 56032
5
Remifentanil Approved Phase 4 132875-61-7 60815
6
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821
7
Minocycline Approved, Investigational Phase 4 10118-90-8 5281021
8
Amoxicillin Approved, Vet_approved Phase 4,Phase 3 26787-78-0 33613 2171
9
Metronidazole Approved Phase 4 443-48-1 4173
10
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
11
Etoricoxib Approved, Investigational Phase 4 202409-33-4 123619
12
Benzocaine Approved Phase 4 1994-09-7, 94-09-7 2337
13
Tigecycline Approved Phase 4 220620-09-7 5282044
14
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4 437-38-7 3345
15
Rocuronium Approved Phase 4 119302-91-9, 143558-00-3 441290
16
Vitamin C Approved, Nutraceutical Phase 4 50-81-7 5785 54670067
17 tannic acid Approved, Nutraceutical Phase 4
18 Gastrointestinal Agents Phase 4
19 Sodium Channel Blockers Phase 4
20 Coagulants Phase 4
21 Hemostatics Phase 4
22 Anesthetics Phase 4,Phase 2,Phase 3
23 Diuretics, Potassium Sparing Phase 4
24 Peripheral Nervous System Agents Phase 4
25 Anesthetics, Local Phase 4
26 Anti-Arrhythmia Agents Phase 4
27 Anti-Inflammatory Agents Phase 4
28 Central Nervous System Depressants Phase 4
29 Analgesics Phase 4
30 Cholagogues and Choleretics Phase 4
31 Adrenergic Agents Phase 4
32 Narcotics Phase 4
33 Adrenergic Agonists Phase 4
34 Adrenergic alpha-2 Receptor Agonists Phase 4
35 Adrenergic alpha-Agonists Phase 4
36 Neurotransmitter Agents Phase 4
37 Cyclooxygenase 2 Inhibitors Phase 4
38 Cyclooxygenase Inhibitors Phase 4
39 Analgesics, Non-Narcotic Phase 4
40 Trace Elements Phase 4
41 Analgesics, Opioid Phase 4
42 Anesthetics, Dissociative Phase 4
43 Anesthetics, General Phase 4
44 Anesthetics, Intravenous Phase 4
45 Hypnotics and Sedatives Phase 4
46 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2
47 Vitamins Phase 4
48 beta-Lactamase Inhibitors Phase 4,Phase 3
49 Excitatory Amino Acid Antagonists Phase 4
50 Excitatory Amino Acids Phase 4

Interventional clinical trials:

(show top 50) (show all 106)
id Name Status NCT ID Phase
1 Efficacy and Safety of Floseal for the Haemostasis During Laparoscopic Cholecystectomy in Acute Cholecystitis (GLA) Unknown status NCT01126281 Phase 4
2 Vitamin C Efficacy in Reducing Post Operative Pain Completed NCT01322061 Phase 4
3 Anesthesia With Propofol, Dexmedetomidine and Lidocaine Infusions for Laparoscopic Cholecystectomy Completed NCT01833819 Phase 4
4 DGT Versus TPS in Patients With Initial PD Cannulation by Chance; Prospective Multi-center Study Completed NCT01744847 Phase 4
5 Pain Post Abdominal Laparoscopy Prevention With Arcoxia Completed NCT00565682 Phase 4
6 Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection Completed NCT00195351 Phase 4
7 Biliary Metal Stent Study: Metal Stents for Management of Distal Malignant Biliary Obstruction Completed NCT00280709 Phase 4
8 UDCA for Symptomatic Gallstone Disease Completed NCT00161083 Phase 4
9 Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI) Completed NCT00230971 Phase 4
10 Extended Antibiotic Therapy in Postoperative of Laparoscopic Cholecystectomy in Acute Cholecystitis Recruiting NCT02057679 Phase 4
11 Effect of Intraoperative Nefopam on Acute Pain After Remifentanil Based Anesthesia Recruiting NCT02493231 Phase 4
12 Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery Recruiting NCT02812186 Phase 4
13 Outcome of IV Acetaminophen Use in Laparoscopic Cholecystectomies in Patients at Risk of OSA Withdrawn NCT02056678 Phase 4
14 Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections. Withdrawn NCT00463762 Phase 4
15 Drainage is Not Necessary Procedure After Laparoscopic Cholecystectomy Due to Severe Acute Cholecystitis Unknown status NCT01625247 Phase 3
16 Single Port Access (SPA) Cholecystectomy Versus Standard Laparoscopic Cholecystectomy Unknown status NCT00904865 Phase 2, Phase 3
17 A Prospective Validation Study of Albumin Kinetics With Tracer 123 I-HSA Unknown status NCT01686776 Phase 3
18 Acute Cholecystitis - Early Laparoscopic Surgery Versus Antibiotic Therapy and Delayed Elective Cholecystectomy Completed NCT00447304 Phase 3
19 Place of Antibiotics in the Postoperative Acute Lithiasic Cholecystitis Completed NCT01015417 Phase 3
20 Doripenem in the Treatment of Complicated Intra-Abdominal Infections Completed NCT00229060 Phase 3
21 Doripenem in the Treatment of Complicated Intra-Abdominal Infections Completed NCT00210938 Phase 3
22 Small-incision Open Cholecystectomy or Laparoscopic Cholecystectomy for Gallbladder Disease Completed NCT00370344 Phase 2, Phase 3
23 Surgery Or Lifestyle Intervention for Type 2 Diabetes (SOLID) Completed NCT01040468 Phase 3
24 Indications for Gallbladder Surgery in Gallstone Disease Completed NCT01190280 Phase 3
25 Comparison of Endoscopic Sphincterotomy Plus Large-balloon Dilatation and Conventional Treatment for Large CBD Stones Completed NCT02592811 Phase 3
26 A Randomized Controlled Trial on EGBD vs PC for Acute Cholecystitis. Recruiting NCT02212717 Phase 2, Phase 3
27 Piperacllin Versus Placebo in Patients Undergoing Surgery for Acute Cholecystitis Recruiting NCT02619149 Phase 3
28 Natural Orifice Transgastric Endoscopic Surgical Removal of the Gallbladder Unknown status NCT01174069 Phase 1, Phase 2
29 Does it Make Sense to Give Postoperative Antibiotics to Patients With an Uncomplicated Acute Cholecystitis Completed NCT00323648 Phase 2
30 Comparisons of Intravenous Ceftriaxone With Intravenous Moxifloxacin in ERCP Completed NCT02098486 Phase 2
31 EUS-guided Transenteric Drainage With a Novel Lumen-apposing Metal Stent Recruiting NCT03002051 Phase 2
32 Near Infrared Fluorescence Cholangiography (NIRF-C) During Cholecystectomy -- Use in Acute Cholecystitis Sub-Study Completed NCT02070627 Phase 1
33 Transvaginal Cholecystectomy Using Endoscopic Assistance Withdrawn NCT00815438 Phase 1
34 Acute Cholecystitis: Early Versus Delayed Laparoscopic Cholecystectomy; Randomized Prospective Study Unknown status NCT02130245
35 Transient ECG Changes in Patients With Acute Biliary Disease Unknown status NCT01706068
36 Comparison of Effect on Quality of Recovery Outcome Between Systemic Lidocaine and Dexamethasone in Patients Undergoing Laparoscopic Cholecystectomy Unknown status NCT02224170
37 Role of the Right Portal Pedicle and Rouviere's Sulcus as an Anatomic Landmark in Laparoscopic Cholecystectomy Unknown status NCT02133027
38 Efficacy of Proficiency-based Versus Free Laparoscopic Training in Cholecystectomy on a Virtual Reality Simulator Unknown status NCT01615549
39 Prospective Validation of "Cholecystectomy First" Strategy for Gallstone Migration Unknown status NCT02461147
40 Functional MRC With Eovist for Acute Cholecystitis Completed NCT02100358
41 Correlation Between Power Doppler and Intraoperative Findings of Chronic and Acute Cholecystitis Completed NCT02156947
42 FDG-PET/CT in the Evaluation of Patients With Suspected Cholecystitis Completed NCT00590395
43 The Real World of Acute Cholecystitis Completed NCT02796443
44 Harmonic in Laparoscopic Cholecystectomy for Acute Cholecystitis Completed NCT00746850
45 Prospective Trial for Endoscopic Ultrasound Guided Gallbladder Drainage for Acute Cholecystitis in High Risk Patients Completed NCT01146743
46 The Clinical Outcomes of the Percutaneous Cholecystostomy, Supportive Care Versus Cholecystectomy. Completed NCT01894321
47 The Role of Antibiotic Treatment in Patients With Acute Mild Cholecystitis - A Prospective Randomized Controlled Trial Completed NCT00557453
48 Is it Fair to Use Antibiotics After Laparoscopic Cholecystectomy for the Patients With Acutely Inflamed Gallbladder? Completed NCT02490293
49 Endoscopic Nasogallbladder Drainage Versus Gallbladder Stenting Before Cholecystecomy Completed NCT02394327
50 Early Versus Delayed Cholecystectomy Completed NCT03122054

Search NIH Clinical Center for Cholecystitis

Cochrane evidence based reviews: cholecystitis

Genetic Tests for Cholecystitis

Genetic tests related to Cholecystitis:

id Genetic test Affiliating Genes
1 Cholecystitis 29

Anatomical Context for Cholecystitis

MalaCards organs/tissues related to Cholecystitis:

39
Liver, B Cells, Testes, Bone, Colon, Bone Marrow, Breast

The Foundational Model of Anatomy Ontology organs/tissues related to Cholecystitis:

18
The Gallbladder

Publications for Cholecystitis

Articles related to Cholecystitis:

(show top 50) (show all 1454)
id Title Authors Year
1
Neutropenic acute acalculous cholecystitis (AAC) in a 12-year-old boy with T-acute lymphoblastic leukemia successfully managed with conservative treatment. ( 28085529 )
2017
2
Validation of TG13 severity grading in acute cholecystitis: Japan-Taiwan collaborative study for acute cholecystitis. ( 28419779 )
2017
3
Embryonic cholecystitis and defective gallbladder contraction in the Sox17-haploinsufficient mouse model of biliary atresia. ( 28432216 )
2017
4
Expanding role of percutaneous cholecystostomy and interventional radiology for the management of acute cholecystitis: An analysis of 144 patients. ( 28506680 )
2017
5
Emphysematous Cholecystitis in a patient with Metastatic Pancreatic Neuroendocrine Tumour. ( 28062742 )
2017
6
Recurre of gallstone disease following non-surgical treatment of acute cholecystitis in the elderly population. ( 28396133 )
2017
7
Laparoscopic cholecystectomy in the treatment of acute cholecystitis: comparison of results between early and late cholecystectomy. ( 28451027 )
2017
8
New era in acute cholecystitis treatment: encouraging results for interventional endoscopists. ( 27986118 )
2017
9
Subspecialty approach for the management of acute cholecystitis: an alternative to acute surgical unit model of care. ( 28512772 )
2017
10
Post-ERCP Emphysematous Cholecystitis in a Young Woman: A Rare and Potentially Fatal Complication. ( 28421150 )
2017
11
Risk factors for poor outcomes of children with acute acalculous cholecystitis. ( 28499592 )
2017
12
Microbiologic Data in Acute Cholecystitis: Ten Years' Experience from Bile Cultures Obtained during Percutaneous Cholecystostomy. ( 28394748 )
2017
13
Comprehensive Diagnosis of Bacterial Infection Associated with Acute Cholecystitis Using Metagenomic Approach. ( 28473817 )
2017
14
Efficacy of preoperative percutaneous cholecystostomy in the management of acute cholecystitis according to severity grades. ( 28063415 )
2017
15
Perforated emphysematous cholecystitis managed by endoscopic transpapillary gallbladder drainage. ( 28516371 )
2017
16
MORTALITY OF URGENCY VERSUS ELECTIVE VIDEOLAPAROSCOPIC CHOLECYSTECTOMY FOR ACUTE CHOLECYSTITIS. ( 28489169 )
2017
17
Upregulation of CA 19-9 in Complicated Cholecystitis. ( 28424112 )
2017
18
Hyalinizing Cholecystitis and Associated Carcinoma: A Case Report. ( 28372345 )
2017
19
Antibiotics in acute calculous cholecystitis - do Tokyo guidelines influence the surgeons' practices? ( 28507349 )
2017
20
Outcomes in Older Patients with Grade III Cholecystitis and Cholecystostomy Tube Placement: A Propensity Score Analysis. ( 28069529 )
2017
21
Optimal treatment strategy for acute cholecystitis based on predictive factors: Japan-Taiwan multicenter cohort study. ( 28419741 )
2017
22
Haemorrhagic cholecystitis in a newly anticoagulated patient. ( 28404563 )
2017
23
Severe Murine Typhus Presenting with Acalculous Cholecystitis: A Case Report and Literature Review. ( 28473857 )
2017
24
Idiopathic hypereosinophilic syndrome manifesting with eosinophilic cholecystitis and recurrent gastroenteritis. ( 28378039 )
2017
25
Acute cholecystitis, chronic cholecystitis or gallbladder cancer? ( 28073581 )
2017
26
Cholecystitis in situs inversus totalis. ( 28513106 )
2017
27
Primary gallbladder lymphoma presenting with perforated cholecystitis and hyperamylasaemia. ( 26673049 )
2016
28
A rare case of listeriosis, acute cholecystitis and multiple myeloma. ( 27170703 )
2016
29
Xanthogranulomatous cholecystitis: What every radiologist should know. ( 26981227 )
2016
30
New scoring system for differentiating xanthogranulomatous cholecystitis from gall bladder carcinoma: a tertiary care centre experience. ( 27599003 )
2016
31
Two cases of cystic artery pseudoaneurysm rupture due to acute cholecystitis with gallstone impaction in the neck. ( 27593367 )
2016
32
Cholecystitis and nephrotic syndrome complicating Epstein-Barr virus primary infection. ( 27077634 )
2016
33
Bacterobilia in acute cholecystitis: Bile cultures' isolates, antibiotic sensitivities and antibiotic usage. A study on a Pakistani population. ( 27895353 )
2016
34
Acute acalculous cholecystitis in systemic lupus erythematosus: a rare initial manifestation. ( 27267533 )
2016
35
Disseminated visceral varicella zoster virus presenting with the constellation of colonic pseudo-obstruction, acalculous cholecystitis and syndrome of inappropriate ADH secretion. ( 26899893 )
2016
36
Daclatasvir and Asunaprevir Combination Therapy-induced Hepatitis and Cholecystitis with Coagulation Disorder due to Hypersensitivity Reactions. ( 27980259 )
2016
37
The Treatment of Critically Ill Patients With Acute Cholecystitis. ( 27598871 )
2016
38
Laparoscopic Management of a Very Rare Case: Cystic Artery Pseudoaneurysm Secondary to Acute Cholecystitis. ( 27635274 )
2016
39
Impact of medical or surgical admission on outcomes of patients with acute cholecystitis. ( 27993464 )
2016
40
Emphysematous cholecystitis due to Clostridium perfringens successfully treated by cholecystectomy. ( 27385144 )
2016
41
An Unusual Case of Pain in the Gallbladder Area: Is It Acute Cholecystitis? ( 27876607 )
2016
42
Laparoscopic cholecystectomy for acute calculous cholecystitis: a retrospective study assessing risk factors for conversion and complications. ( 27891173 )
2016
43
Outcome of acute perforated cholecystitis: a register study of over 5000 cases from a quality control database in Germany. ( 27553799 )
2016
44
Cholecystitis as the initial presentation of acute myeloid leukaemia. ( 27982426 )
2016
45
Acute acalculous cholecystitis in systemic lupus erythematosus: a rare initial manifestation. ( 27037657 )
2016
46
C-Kit expression in the gallbladder of guinea pig with chronic calculous cholecystitis and the effect of Artemisia capillaris Thunb on interstitial cells of Cajal. ( 27635195 )
2016
47
Acute cholecystitis and myocardial infarction: a case study with coronary involvement. ( 27525087 )
2016
48
The Sooner, the Better? The Importance of Optimal Timing of Cholecystectomy in Acute Cholecystitis: Data from the National Swedish Registry for Gallstone Surgery, GallRiks. ( 27649704 )
2016
49
The "right" way is not always popular: comparison of surgeons' perceptions during laparoscopic cholecystectomy for acute cholecystitis among experts from Japan, Korea and Taiwan. ( 28026137 )
2016
50
Right hypochondrial abscess: A rare consequence of supportive cholecystitis. ( 27994870 )
2016

Variations for Cholecystitis

ClinVar genetic disease variations for Cholecystitis:

6
id Gene Variation Type Significance SNP ID Assembly Location
1 ABCB4 NM_018849.2(ABCB4): c.1328_1329delAGinsCAA (p.Gln443Profs) indel Pathogenic rs387906528 GRCh37 Chromosome 7, 87072662: 87072663
2 ABCB4 NM_018849.2(ABCB4): c.1633C> G (p.Arg545Gly) single nucleotide variant Pathogenic rs397514620 GRCh37 Chromosome 7, 87069081: 87069081
3 ABCB4 NM_018849.2(ABCB4): c.3629C> G (p.Ser1210Ter) single nucleotide variant Pathogenic rs748842753 GRCh37 Chromosome 7, 87032476: 87032476

Expression for Cholecystitis

Search GEO for disease gene expression data for Cholecystitis.

Pathways for Cholecystitis

GO Terms for Cholecystitis

Cellular components related to Cholecystitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.76 ALB CCK CDH1 F2 GUSB HP
2 extracellular space GO:0005615 9.5 ALB CCK F2 GPT GUSB HP
3 Golgi lumen GO:0005796 8.92 F2 MUC1 MUC2 MUC6

Biological processes related to Cholecystitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 stimulatory C-type lectin receptor signaling pathway GO:0002223 9.54 MUC1 MUC2 MUC6
2 DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator GO:0006978 9.32 MUC1 TP53
3 positive regulation of protein oligomerization GO:0032461 9.26 CCK TP53
4 maintenance of gastrointestinal epithelium GO:0030277 9.16 MUC2 MUC6
5 replicative senescence GO:0090399 8.96 CDKN2A TP53
6 O-glycan processing GO:0016266 8.8 MUC1 MUC2 MUC6

Sources for Cholecystitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....